Neutropenia: state of the knowledge part II
- PMID: 17149403
- DOI: 10.1188/06.ONF.1202-1208
Neutropenia: state of the knowledge part II
Abstract
Purpose/objectives: To summarize the current available evidence for oncology nurses so that they may predict and prevent complications of chemotherapy-induced neutropenia (CIN), provide optimal education to patients, and become familiar with the state of the knowledge of neutropenia by understanding the evidence and guidelines for patients with cancer who may experience CIN.
Data sources: Review of primary literature, meta-analyses, available systematic reviews, clinical practice guidelines, and discussions at the State of the Knowledge on Neutropenia Symposium.
Data synthesis: The evidence for nursing interventions to prevent CIN complications is underdeveloped. Strong empirical support to prevent infection in patients with CIN (e.g., restrictions in diet, isolation procedures, providing accurate patient education) is lacking. Several areas of preventive measures by patients, hand washing, and skin care have a stronger evidence base and should have high priority on patient education plans.
Conclusions: Strong evidence is available for several nursing interventions to prevent infection in patients with CIN. Many existing practices lack empirical support and should be identified and reviewed in the clinical setting for appropriate patient management.
Implications for nursing: Oncology nurses can use the findings from the symposium to revise their care standards for patients anticipated to experience CIN. Research and practice performance improvement projects may be undertaken by oncology nurses to improve the delivery of evidence-based nursing care to this vulnerable patient population.
Similar articles
-
Neutropenia: state of the knowledge part I.Oncol Nurs Forum. 2006 Nov 27;33(6):1193-201. doi: 10.1188/06.ONF.1193-1201. Oncol Nurs Forum. 2006. PMID: 17149402 Review.
-
Oncology nurses' use of National Comprehensive Cancer Network clinical practice guidelines for chemotherapy-induced and febrile neutropenia.Oncol Nurs Forum. 2010 Nov;37(6):765-73. doi: 10.1188/10.ONF.765-773. Oncol Nurs Forum. 2010. PMID: 21059588
-
Neutropenia management with granulocyte colony-stimulating factors: from guidelines to nursing practice protocols.Eur J Oncol Nurs. 2005;9 Suppl 1:S14-23. doi: 10.1016/j.ejon.2005.08.006. Epub 2005 Oct 3. Eur J Oncol Nurs. 2005. PMID: 16207534 Review.
-
Nurses' guide to understanding and implementing the National Comprehensive Cancer Network guidelines for myeloid growth factors.Oncol Nurs Forum. 2007 Mar;34(2):347-53. doi: 10.1188/07.ONF.347-353. Oncol Nurs Forum. 2007. PMID: 17573299 Review.
-
Development and implementation of a risk assessment tool for chemotherapy-induced neutropenia.Oncol Nurs Forum. 2006 Nov 3;33(2):347-52. doi: 10.1188/06.ONF.347-352. Oncol Nurs Forum. 2006. PMID: 16518450
Cited by
-
Nondrug Intervention for Opportunistic Infections in Individuals With Hematological Malignancy: Systematic Review.Interact J Med Res. 2023 Mar 31;12:e43969. doi: 10.2196/43969. Interact J Med Res. 2023. PMID: 37000482 Free PMC article. Review.
-
The Role of Bronchoalveolar Lavage in Therapeutic Antimicrobial Choices for Hematologic Patients with Pulmonary Infiltrates.Medicina (Kaunas). 2025 Jan 14;61(1):118. doi: 10.3390/medicina61010118. Medicina (Kaunas). 2025. PMID: 39859100 Free PMC article.
-
National Cancer Institute Cancer Center designation and 30-day mortality for hospitalized, immunocompromised cancer patients.Cancer Invest. 2010 Aug;28(7):751-7. doi: 10.3109/07357901003735667. Cancer Invest. 2010. PMID: 20504224 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources